Sentences with phrase «renal cell carcinoma»
The treatment of renal cell carcinoma with human leukocyte alpha - interferon.
jcancer.org
A Phase III, Multicenter, Randomized, Placebo - Controlled, Double - Blind Study Of Atezolizumab (Anti − PD - L1 Antibody) As Adjuvant Therapy In Patients With Renal Cell Carcinoma At High Risk Of Developing Metastasis Following Nephrectomy
Based on this finding, the researchers found that similar mutations also occur in renal cell carcinomas in humans.
The company's lead product is for the personalized treatment of advanced renal cell carcinoma and is in phase III clinical development.
Project Title: Identification of molecular alterations associated with the progression of clear cell renal cell carcinoma by mass spectrometric approaches
Expression of drug targets in primary and matched metastatic renal cell carcinoma tumors.
Javidnia says analysis in this study shows pazopanib penetrates the mice's blood - brain barrier when given the equivalent of half of dose given for renal cell carcinoma treatment.
Tang and his colleagues in the laboratory of Dr. David Hsu at the Duke Cancer Institute implanted renal cell carcinoma tumors into mice and then treated the animals with sulfasalazine, a drug that blocks cystine uptake.
«Most renal cell carcinomas learn to escape therapy after a couple of years,» said Robert Weiss, professor of medicine at UC Davis, chief of nephrology at Sacramento VA Medical Center, and head of the kidney cancer working group at the UC Davis Comprehensive Cancer Center.
The researchers began by identifying the genes that often mutate in human renal cell carcinomas.
An FDA approved drug to treat renal cell carcinoma appears to reduce levels of a toxic brain protein linked to dementia in Alzheimer's and Parkinson's diseases when given to animals.
They discovered that overactivation of this pathway, which is observed in some types of cancer such as renal cell carcinoma, melanoma and pancreatic cancer, is important to promote and support the growth of cancer cells in culture and animal models.
Freed SZ, Halperin JP, Gordon M. Idiopathic regression of metastases from renal cell carcinoma.
«Because renal cell carcinoma most often presents as incidental, small, localized, and often indolent tumors in elderly patients with high rates of CKD and comorbidities, competing nononcologic mortality risks should be carefully considered when counseling patients.»
Researchers at UC Davis have shown that docosahexaenoic acid (DHA), a fatty acid commonly found in fish and fish oil supplements, reduces renal cell carcinoma invasiveness, growth rate, and blood vessel growth when combined with the anti-cancer therapy regorafenib.
About three - fourths of renal cell carcinoma cases are marked by a missing VHL tumor - suppressor gene, which keeps healthy cells from developing into tumors.
Diets high in meat may lead to an increased risk of developing renal cell carcinoma (RCC) through intake of carcinogenic compounds created by certain cooking techniques, such as barbecuing and pan-frying.
PHIII Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy.
Vascularity of primary and metastatic renal cell carcinoma specimens.
In an effort to further exploit the potential of Pexa - Vec to activate the immune system to fight cancer, as seen in McDonald's preclinical data, SillaJen recently announced a new clinical trial in collaboration with New York - based Regeneron Inc. to test Pexa - Vec and REGN2810, a PD - 1 checkpoint inhibitor, in combination against renal cell carcinoma, and recently signed a sponsored research agreement with UCSF to enable joint support of parallel preclinical experiments by McDonald's team.
First - line combination therapy with the programmed death ligand 1 (PD - L1) inhibitor avelumab and the vascular endothelial growth factor receptor tyrosine kinase inhibitor axitinib resulted in encouraging antitumor activity in patients with previously untreated renal cell carcinoma (RCC) and had a manageable toxicity profile, according to the results of the JAVELIN Renal 100 study published in Lancet Oncology.
Contrasting properties of hypoxia - inducible factor 1 (HIF - 1) and HIF - 2 in von Hippel - Lindau - associated renal cell carcinoma
Adults with advanced renal cell carcinoma after targeted therapy against vascular endothelial growth factor (VEGF)
Renin - producing renal cell carcinomas — clinical and experimental investigations on a special form of renal hypertension
A month's treatment for Renal Cell Carcinoma using Pfizer's Sunitinib would cost about Rs 1.75 lakh.
About Blog The KCCure blog covers kidney cancer research news and stories about renal cell carcinoma clinical trials and treatments to cure kidney cancer.
New York, NY About Blog Kidney cancer, renal cell carcinoma news and clinical reviews, symptoms, pain, treatments.
The most common form of this disease is called clear cell renal cell carcinoma (ccRCC).
Tumor B7 - H1 is associated with poor prognosis in renal cell carcinoma patients with long - term follow - up.
Systemic Therapy of Advanced Renal Cell Carcinoma — Summary of Main Presentations at the ASCO, ASCO - GU and ESMO 2012 Annual Meetings
What's more, one patient who had failed multiple prior treatments for renal cell carcinoma had a confirmed durable partial response and two patients with colorectal cancer had prolonged stable disease.
Axitinib, a drug used to treat renal cell carcinoma, has been shown to be effective at inhibiting the Abl kinase activity in patients with BCR - ABL1 (T315I).
Researchers studied food questionnaires for 335 people with renal cell carcinoma, the most common form of kidney cancer, and 337 healthy controls.
He past away from Renal Cell Carcinoma.
Renal cell carcinoma tumors have three different evolutionary fates, each associated with specific clinical outcomes.
Most renal cell carcinomas are a subtype called clear cell carcinoma.
The results are explained in «Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort,» featured in the Feb. 15 issue of Cancer.
Mr. Kaisary's main interest is the diagnosis and management of prostate cancer and benign prostate disease together with bladder cancer and renal cell carcinoma.
Renal cell carcinoma, also known by the eponym Grawitz tumor, is the most common form of kidney cancer arising from the renal tubule.
Spontaneous remission is more likely with certain kinds of cancer, such as melanoma and renal cell carcinoma.
In the last few years, much progress has been made in this field of cancer research, also for the treatment of renal cell carcinomas.
Despite decades of effort, however, researchers were unable to develop a mouse model of renal cell carcinoma — until now.
A gene known to control brain growth and development is heavily involved in promoting clear cell renal cell carcinoma, the most common form of kidney cancer, researchers from Mayo Clinic in Florida are reporting.
The Ogretmen laboratory screened previously reported microarray data sets of several human tumor tissues (metastatic head and neck squamous cell carcinoma, melanoma, and renal cell carcinoma) and showed that, in these samples, only the levels of CerS4 were significantly decreased.
However, death rates due to renal cell carcinoma (kidney cancer) have not decreased, indicating that surgery may be of little or no benefit to some patients.